SASeda Kutluğ Ağaçkıran

Seda Kutluğ Ağaçkıran

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Seda Kutluğ Ağaçkıran has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Common femoral vein wall thickness as a supportive imaging marker in the differential diagnosis of Behçet’s uveitis

    by Seda Kutluğ Ağaçkiran, Esra Kardeş, Abdulbaki̇ Ağaçkiran, Haner Di̇rEskeneli̇, Fatma Ali̇bAz-Öner

    Background/aim: Ocular involvement is a major cause of morbidity in Behçet’s disease (BD), and its diagnosis may be challenging, particularly for patients with isolated ocular manifestations or incomplete fulfillment of diagnostic criteria. Increased common femoral vein (CFV) wall thickness measured by Doppler ultrasonography (US) has previously been shown to be a sensitive and specific marker for systemic BD. This study aimed to evaluate whether CFV wall thickness measurement may serve as a supportive tool in distinguishing Behçet’s uveitis (BU) from other forms of inflammatory uveitis. Materials and methods: This retrospective study included 45 patients with BU fulfilling the International Study Group criteria for BD and 72 patients with non-BD uveitis of infectious and noninfectious etiologies. Bilateral CFV wall thickness was measured using color Doppler US by a radiologist blinded to the clinical data. Group comparisons were performed and multivariate linear regression analyses were used to assess whether BU was independently associated with increased CFV wall thickness after adjustment for potential confounders. Exploratory analyses additionally evaluated the effects of disease duration and systemic treatment status. Results: Mean CFV wall thickness was significantly higher in the BU group than in the non-BU group in both extremities (p < 0.001). BU remained an independent predictor of increased CFV wall thickness after adjustment for sex and venous Doppler findings. Additional exploratory analyses adjusting for disease duration and current systemic treatment status did not change this association. Conclusion: CFV wall thickness measured by Doppler US was significantly increased in patients with BU compared to other forms of inflammatory uveitis. These findings suggest that CFV wall thickness may serve as a supportive or adjunctive imaging marker in selected cases to assist in the differential diagnosis of ocular BD.


  • Clinical course of paediatric-onset Behçet’s disease in young adulthood

    by Tugce Bozkurt, Mehmet Yildiz, Rabia Deniz, Ayten Yazici, Murat Karabacak, Hakan Karatas, Seda Kutluğ-Ağaçkıran, Aybuke Gunalp, Elif Kilic Konte, Sezgin Şahin, et al.

    Although Behçet's disease (BD) typically manifests in the second or third decade of life, initial symptoms may appear at a younger age. It may also take a longer time for the full disease phenotype to develop after the first symptom onset in pediatric patients. In this study we aimed to assess the clinical course of pediatric-onset BD in adulthood period. The files of 112 patients diagnosed with BD before the age of 18, selected from five tertiary clinics, were retrospectively examined. Patients with a follow-up of less than six months were excluded. The study comprised 93 patients with pediatric-onset BD, of whom 64.5% (n = 60) were male. The median age of diagnosis was 15 years (13–17). Major organ involvement was present in 49 (52.5%) patients. The most commonly affected organ was the eye (29%). Sixty-eight (73.1%) patients had follow-up data in adulthood. Fourty patients had only mucocutaneous manifestations in the pediatric period. During follow-up in adulthood, 15 (53.3% were male) had new major organ involvement with a mean of 10.1 (SD: 7.9) years after diagnosis. Twenty-eight patients (41.1%) experienced major organ involvement during the pediatric period. In adulthood follow-up, 12 (42.8%) developed new major organ involvement and/or relapse of the same organ. Eighteen (26.5%) of 68 pediatric-onset BD patients had new major organ involvement, and 9 (13.2%) had a relapse during adulthood follow-up. Our results showed that nearly one-third of pediatric BD patients have a new major organ involvement or a relapse in adulthood. Regular follow-up of pediatric BD patients in adulthood is essential to prevent long-term damage in this disease subset.


  • Common femoral vein wall thickness measurement by Doppler ultrasonography is an accurate diagnostic test for Behçet’s Disease both in supine and standing positions

    by Rabia Ergelen, Seda Kutluğ Ağaçkıran, Haner Direskeneli, Fatma Alibaz-Oner

    Objectives: We recently reported the first controlled Doppler ultrasonography (US) study demonstrating increased common femoral vein (CFV) thickness in Behçet’s Disease (BD). Standard lower extremity venous Doppler US is performed in erect position. In order to confirm accuracy and applicability of method, we measured CFV thickness in both supine and standing positions in this study. Method: We included sex and age-matched 42 BD patients and 41 healthy controls (HCs). After routine visits, bilateral CFV thickness was measured with Doppler US both in supine and standing positions. Results: Bilateral CFV thickness was significantly higher in BD than in HC. There were no statistically significant differences in measurements of CFV wall thickness between standing and supine positions in both groups. Conclusions: CFV measurement by Doppler US is a new and non-invasive diagnostic tool for the diagnosis of BD. Our study confirmed that patient position does not affect CFV wall thickness measurement for diagnosis of BD.


  • Increased inferior vena cava wall thickness as a sign of extensive venous inflammation in Behçet’s Disease

    by Seda Kutluğ Ağaçkıran, Murat Sünbül, Zekeriya Doğan, Haner Direskeneli, Fatma Alibaz-Oner

    Introduction/objectives Behçet’s disease (BD) affects both arterial and venous vessels. We have previously shown that common femoral vein wall thickness (WT) is increased in BD and can be used as a diagnostic test. However, there is limited data assessing large veins. Therefore, this study seeks to assess inferior vena cava wall thickness (IVC) by transthoracic echocardiography (TTE) in BD compared to healthy controls (HC). Methods Age- and gender-matched 70 BD patients and 51 HC were included. IVC wall thickness and common femoral vein WT were measured by TTE and Doppler ultrasonography, respectively. All examinations were performed on the same day as the clinical assessment. Results The mean IVC wall thickness of BD patients was significantly higher than HC (2.9 mm (0.3) vs 2.6 mm (0.3), p < 0.001). Patients with mucocutaneous involvement (2.8 mm (0.3)) and major organ involvement (2.9 mm (0.3)) had significantly thicker walls compared to HC (p = 0.003, p < 0.001, respectively). IVC wall thickness was higher in patients with vascular involvement compared to those with nonvascular major organ involvement (3.1 mm (0.3) vs 2.8 mm (0.2), p = 0.04). There was a moderate correlation between IVC and common femoral vein WT (r = 0.49 for the right, r = 0.43 for the left, p = 0.01 for both). Conclusion This study shows that venous wall inflammation is not limited to lower extremity veins and is also present in IVC walls of BD patients regardless of IVC involvement. Vascular wall inflammation is probably a widespread vascular event of all venous walls in BD. Key Points • Venous wall inflammation is not limited to lower extremity veins and is present also in IVC wall in Behçet’s disease. • Extensive venous wall inflammation in Behçet’s disease includes large venous structures despite not being clinically involved.


  • Common femoral vein wall thickness measurement as a diagnostic test in suspected Behçet’s disease

    by Fatma Alibaz-Oner, Rabia Ergelen, Seda Kutluğ-Ağaçkıran, Fatma Temiz, Tulin Ergun, Haner Direskeneli

    Fatma Alibaz-Oner, Rabia Ergelen, Seda Kutluğ-Ağaçkıran, Fatma Temiz, Tulin Ergun, Haner Direskeneli; Common femoral vein wall thickness measurement as a diagno


  • THE COURSE AND OUTCOMES OF COVID-19 IN PATIENTS WITH TAKAYASU ARTERITIS: CASE SERIES OF 15 PATIENTS FROM A TERTIARY SINGLE CENTER

    by Gizem Sevik, Seda Kutluğ Ağaçkıran, Kerem Yiğit Abacar, Alida Aliyeva, Haner Direskeneli, Fatma Alibaz-Öner

    Aim:Coronavirus disease-2019 (COVID-19) has affected more than three hundred million individuals, and many risk factors for increased mortality and morbidity in COVID-19 have been defined. There are many studies evaluating the course of COVID-19 in inflammatory rheumatic diseases, however, fewer data are available for patients with Takayasu arteritis (TAK). This study assessed the characteristics and outcomes of TAK patients with COVID-19. Material and Methods:A phone survey was conducted among TAK patients that are followed up in our clinic between February 2021 and March 2021. All patients were asked whether they were diagnosed with COVID-19 during the pandemic. The patients who had a history of COVID-19 were asked about the symptoms, hospitalization status, and treatment received for COVID-19. Information about their chronic diseases was obtained from the patient files. Results:Among 118 TAK patients, 15 had COVID-19 during the first year of the pandemic; 13 were female, and the mean age was 42.5±12.04 years. Nine of the patients were taking prednisone therapy, 12 were taking conventionally synthetic disease-modifying antirheumatic drugs (csDMARDs), 7 patients were taking biological disease-modifying antirheumatic drugs (bDMARDs), and 5 patients were taking a combination of csDMARD and bDMARD therapy when they were diagnosed with COVID-19. Two patients were hospitalized, and one of them was admitted to the intensive care unit for 5 days. All the patients fully recovered, and there was no mortality related to COVID-19. Conclusion:Our data suggest that there is no increased risk for morbidity or mortality related to COVID-19 in TAK patients.

  • Open Access

    RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy

    by İlKay Ergenç, Haluk Tarık Kani, Murat Karabacak, Elif Cömert Özer, Shahin Mehdiyev, Fuad Jafarov, Kerem Yiğit Abacar, Seda Kutluğ Ağaçkıran, Gizem Sevik, Rahmi Aslan, et al.

    Cite this article as: Ergenç İ, Kani HT, Karabacak M, et al. RE: risk of HBV reactivation in HBsAg negative and anti-HBc IgG positive patients receiving biologic therapy. Turk J Gastroenterol. 2023;34(3):310.


  • Open Access

    Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B

    by İlKay Ergenç, Haluk Tarık Kani, Murat Karabacak, Elif Cömert Özer, Shahin Mehdiyev, Fuad Jafarov, Kerem Yiğit Abacar, Seda Kutluğ Ağaçkıran, Gizem Sevik, Rahmi Aslan, et al.

    Background: The risk of hepatitis B reactivation in hepatitis B surface antigen-negative phase of hepatitis B virus-infected patients exposed to biologic agents is not clear. We aimed to investigate the reactivation rate in hepatitis B surface antigen-negative phase of hepatitis B virus-infected patients after biologic therapy. Methods: Patients followed at gastroenterology, rheumatology, and dermatology clinics with a diagnosis of immune-mediated inflammatory diseases were screened. Immune-mediated inflammatory diseases patients exposed to biologic agents with a negative hepatitis B surface antigen and positive hepatitis B core immunoglobulin G antibody were included in the study. Results: We screened 8266 immune-mediated inflammatory disease patients, and 2484 patients were identified as exposed to biologic agents. Two hundred twenty-one patients were included in the study. The mean age was 54.08 ± 11.69 years, and 115 (52.0%) patients were female. The median number of different biologic subtype use was 1 (range: 1-6). The mean biologic agent exposure time was 55 (range: 2-179) months. One hundred and fifty-two (68.8%) patients used a concomitant immunomodulatory agent, and 84 (38.0%) patients were exposed to corticosteroids during biologic use. No hepatitis B reactivation with a reverse seroconversion of hepatitis B surface antigen positivity was seen. Antiviral prophylaxis for hepatitis B was applied to 48 (21.7%) patients. Hepatitis B virus-DNA was screened in 56 (25.3%) patients prior to the biologic exposure. Two patients without antiviral prophylaxis had hepatitis B virus-DNA reactivation with a negative hepatitis B surface antigen during exposure to the biologic agent. Conclusion: We found 2 reactivations and no hepatitis B surface antigen seroconversion in our cohort. Antiviral prophylaxis for patients exposed to biologic agents may need to be discussed in more detail. Cite this article as: Ergenç İ, Kani HT, Karabacak M, et al. Biologic therapy carries a very low risk of reactivation in hepatitis B surface antigen-negative phase of hepatitis B. Turk J Gastroenterol. 2023;34(2):156-160.


  • Pulmonary arterial wall thickness increased in Behçet’s disease patients with major organ involvement: Is it a sign of severity?

    by Seda Kutluğ Ağaçkıran, Murat Sünbül, Zekeriya Doğan, Derya Kocakaya, Semih Kayacı, Haner Direskeneli, Fatma Alibaz-Oner

    Behçet’s Disease (BD) is a unique systemic vasculitis mainly involving veins in contrast to other vasculitides. Prior studies showed that pulmonary arteries (PA) have a similar structure to systemic veins. In this study, we aimed to assess PA wall thickness by transthoracic echocardiography (TTE) in BD patients compared with healthy controls (HC) and patients with non-inflammatory pulmonary embolism (NIPE). Patients with BD (n = 77), NIPE (n = 33) and HC (n = 57) were studied. PA wall thickness was measured from the mid-portion of the main PA with TTE by two cardiologists blinded to cases. PA wall thickness was significantly lower in HC (3.6 (0.3) mm) compared with NIPE (4.4 (0.5) mm) and BD (4.4 (0.6) mm) (p< 0.001 for both). PA wall thickness was similar between BD and NIPE (p= 0.6). Among patients with BD, PA wall thickness was significantly higher in patients with major organ involvement compared with mucocutaneous limited disease (4.7 (0.4) mm vs 3.7 (0.4) mm, p< 0.001), HC and NIPE (p< 0.001 and p= 0.006, respectively). PA wall thickness was comparable between patients with vascular and non-vascular major organ involvement (4.6 (0.5) mm vs 4.7 (0.3) mm, p= 0.3). We observed that PA wall thickness was significantly higher in BD with major organ involvement compared with patients with only mucocutaneous limited disease, HC and NIPE. These results suggest that increased PA wall thickness may be a sign of severe disease with major organ involvement in BD.


  • Myocardial involvement in Behçet’s disease may be higher in patients with Neuro-Behçet’s disease: a speckle tracking echocardiographic study

    by Murat Sunbul, Ipek Gursoy Midi, Seda Kutlug Agackiran, Esin Engin, Selen Ucem, Fatma Alibaz-Oner, Nurten Sayar, Haner Direskeneli, Beste Ozben Sadıc

    Behcet’s disease (BD) may present with life threating complications including neurological and cardiovascular involvement. Neuro-Behcet’s disease (NBD) is one of the most important causes of morbidity and mortality in patients with BD. The aim of the present study is to investigate whether patients with NBD are different than BD patients with other manifestations in terms of subclinical myocardial dysfunction. Forty patients with NBD (23 female, mean age: 42.4 ± 9.4 years), 40 patients with BD (9 female, mean age: 39.7 ± 9.0 years) and 40 controls (20 male, mean age: 41.8 ± 6.5 years) were consecutively included in the study. All subjects underwent a transthoracic echocardiography for evaluation of left ventricular (LV) and atrial (LA) functions with two-dimensional (2D) speckle tracking echocardiography (STE). Baseline characteristics, clinical data, LV dimensions, systolic and diastolic functions were all in normal range among the groups. LV global longitudinal strain (LV-GLS) was significantly lower in patients with NBD and BD patients without neurologic involvement compared to controls. LA conduit strain was significantly lower in patients with NBD compared to controls. Patients with both parenchymal NBD and vascular NBD manifestations had significantly lower LV-GLS and LA conduit strain compared to controls. Linear regression analysis demonstrated that among cardiovascular risk factors only presence of NBD was the independent predictor of LV-GLS. BD is associated with impaired LV and LA functions. LV-GLS and LA conduit strains of the patients with NBD were lower. NBD was an independent predictor of LV-GLS, suggesting a link between neurological manifestations and cardiac dysfunction in BD patients.